98 related articles for article (PubMed ID: 9880620)
1. Brown fat necrosis in the setting of congenital heart disease and prostaglandin E1 use: a case report.
Raboi CA; Smith W
Pediatr Radiol; 1999 Jan; 29(1):61-3. PubMed ID: 9880620
[TBL] [Abstract][Full Text] [Related]
2. Resolution of calcific brown fat necrosis associated with prostaglandin therapy for cyanotic congenital heart disease in neonates: report of two cases.
Miller SF
Pediatr Radiol; 2004 Nov; 34(11):919-23. PubMed ID: 15185042
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E1 in infants with congenital heart disease: Indian experience.
Saxena A; Sharma M; Kothari SS; Juneja R; Reddy SC; Sharma R; Bhan A; Venugopal P
Indian Pediatr; 1998 Nov; 35(11):1063-9. PubMed ID: 10216540
[TBL] [Abstract][Full Text] [Related]
4. Cortical Hyperostosis after Long-Lasting Prostaglandin E1 Treatment in a Newborn with Complex Congenital Heart Disease.
Celona A; Giardina C; Pappalardo S; Secinaro A; Oreto L; Agati S; Romeo P
J Pediatr; 2020 Nov; 226():302-303. PubMed ID: 32721399
[No Abstract] [Full Text] [Related]
5. Prostaglandin E1: first stage palliation in neonates with congenital cardiac defects.
Reddy SC; Saxena A
Indian J Pediatr; 1998; 65(2):211-6. PubMed ID: 10771966
[TBL] [Abstract][Full Text] [Related]
6. Cortical hyperostosis secondary to prolonged use of prostaglandin E1.
de Almeida JF; Kimura H; Hercowitz LH; Korkes H; Troster EJ
Clinics (Sao Paulo); 2007 Jun; 62(3):363-6. PubMed ID: 17589681
[No Abstract] [Full Text] [Related]
7. Cortical hyperostosis: a complication of prostaglandin E1 treatment in congenital heart disease.
Smet MH; Marchal G; Lambert L; Devlieger H; Gewillig M
J Belge Radiol; 1989 Oct; 72(5):377-80. PubMed ID: 2600053
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E1 in infants with critical congenital heart disease.
Dungan WT
Gaoxiong Yi Xue Ke Xue Za Zhi; 1985 Jan; 1(1):71-4. PubMed ID: 2454319
[No Abstract] [Full Text] [Related]
9. Prostaglandin E1 treatment in patent ductus arteriosus dependent congenital heart defects.
Tálosi G; Katona M; Rácz K; Kertész E; Onozó B; Túri S
J Perinat Med; 2004; 32(4):368-74. PubMed ID: 15346826
[TBL] [Abstract][Full Text] [Related]
10. Cortical hyperostosis simulating osteomyelitis after short-term prostaglandin E1 infusion.
Kalloghlian AK; Frayha HH; deMoor MM
Eur J Pediatr; 1996 Mar; 155(3):173-4. PubMed ID: 8929722
[TBL] [Abstract][Full Text] [Related]
11. Complications of Long-Term Prostaglandin E1 Use in Newborns With Ductal-Dependent Critical Congenital Heart Disease.
Alhussin W; Verklan MT
J Perinat Neonatal Nurs; 2016; 30(1):73-9. PubMed ID: 26813395
[TBL] [Abstract][Full Text] [Related]
12. Case report: soft tissue and perivisceral calcification occurring in an infant: a case of brown fat necrosis.
Higgins JN; Haddock JA; Shaw DG
Br J Radiol; 1993 Apr; 66(784):366-8. PubMed ID: 8495293
[TBL] [Abstract][Full Text] [Related]
13. Neonatal urticaria due to prostaglandin E1.
Carter EL; Garzon MC
Pediatr Dermatol; 2000; 17(1):58-61. PubMed ID: 10720990
[TBL] [Abstract][Full Text] [Related]
14. Generalized periosteal reaction and tissue swelling secondary to prolonged prostaglandin E1 infusion and venous stasis: a case report.
Alan S; Uçar T; Erdeve O; Atasay B; Arsan S; Atalay S
Turk J Pediatr; 2013; 55(5):543-5. PubMed ID: 24382539
[TBL] [Abstract][Full Text] [Related]
15. Transporting newborn infants with suspected duct dependent congenital heart disease on low-dose prostaglandin E1 without routine mechanical ventilation.
Browning Carmo KA; Barr P; West M; Hopper NW; White JP; Badawi N
Arch Dis Child Fetal Neonatal Ed; 2007 Mar; 92(2):F117-9. PubMed ID: 16905574
[TBL] [Abstract][Full Text] [Related]
16. The harlequin color change and association with prostaglandin E1.
Rao J; Campbell ME; Krol A
Pediatr Dermatol; 2004; 21(5):573-6. PubMed ID: 15461766
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Prostaglandin E1 Infusion for Newborns with Critical Congenital Heart Disease.
Aykanat A; Yavuz T; Özalkaya E; Topçuoğlu S; Ovalı F; Karatekin G
Pediatr Cardiol; 2016 Jan; 37(1):131-4. PubMed ID: 26260095
[TBL] [Abstract][Full Text] [Related]
18. [Complications of prostaglandin E1 treatment of congenital heart disease in paediatric medical intensive care].
Lucron H; Chipaux M; Bosser G; Le Tacon S; Lethor JP; Feillet F; Burger G; Monin P; Marçon F
Arch Mal Coeur Vaiss; 2005 May; 98(5):524-30. PubMed ID: 15966603
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E1 overdose in a term neonate with congenital heart disease.
Gorodetsky RM; Toole BM; Schult RF; Wiegand TJ
Clin Toxicol (Phila); 2019 Jun; 57(6):420-421. PubMed ID: 30451018
[No Abstract] [Full Text] [Related]
20. Response to prostaglandin E1 in neonates with intracranial arteriovenous malformation treated for suspected congenital heart disease.
Covert RF
Pediatr Cardiol; 1994; 15(2):81-4. PubMed ID: 7997419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
